Cargando…
Diagnosis and Management of Preeclampsia: Suggested Guidance on the Use of Biomarkers
Objective It is a challenge to consider preeclampsia (PE) diagnosis and management in low and middle-income settings, where it represents a major public health concern. The placenta is the underlying cause of disease, and the plasma concentrations of proangiogenic and antiangiogenic factors release...
Autores principales: | Costa, Maria Laura, Cavalli, Ricardo de Carvalho, Korkes, Henri Augusto, Cunha Filho, Edson Vieira da, Peraçoli, José Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948147/ https://www.ncbi.nlm.nih.gov/pubmed/35468644 http://dx.doi.org/10.1055/s-0042-1744286 |
Ejemplares similares
-
Association of LEPTIN and other inflammatory markers with preeclampsia: A systematic review
por: Veiga, Eduardo Carvalho de Arruda, et al.
Publicado: (2022) -
Prediction and prevention of preeclampsia by physicians in Brazil: An original study
por: da Cunha Filho, Edson Vieira, et al.
Publicado: (2022) -
Pre-eclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
por: De Oliveira, Leandro Gustavo, et al.
Publicado: (2021) -
Negative Correlation between Placental Growth Factor and Endocan-1 in Women with Preeclampsia
por: Hentschke, Marta Ribeiro, et al.
Publicado: (2018) -
Association between Adverse Maternal Clinical Outcomes and Imbalance of Cytokines and Angiogenic Factors in Preterm Preeclampsia
por: Nunes, Priscila Rezeck, et al.
Publicado: (2021)